• 

  GLP-1 Drugs and Brain Health: Can They Reduce Alzheimer’s Risk?
• 

  Review Questions Impact of Anti-Amyloid Drugs
• 

  Most Older Adults Would Take an Alzheimer’s Blood Test, Study Finds
• 

  New Drug for Rare Childhood Dementia Wins FDA Accelerated Approval
• 

  Does CTE Cause Aggression? Study Finds Link to Dementia Instead
• 

  Targeting the ApoE4 Gene to Treat Alzheimer’s
• 

  Can Brain Training Reduce Dementia Risk 20 Years Later?
• 

  Could Long COVID Brain Changes Signal Future Cognitive Decline?
• 

  Common Pneumonia Bacteria in the Eye Linked to Alzheimer’s
• 

  Exercise and Blood Pressure Control Help the Brain, But Results May Take Years
• 

  Company Pulls Alzheimer’s Drug Application After EU Rejection
• 

  Low-Dose Lithium Trial Sets the Stage for Future Alzheimer’s Studies
• 

  Could Skin Punch Biopsy Help Early Detection of Parkinson’s and Other Diseases?
• 

  Treating ALS: Multiple ALS Drugs Move to Phase 3 Trials
• 

  What Alzheimer’s Biomarkers Reveal in Black and Hispanic Americans

12Next